Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content

Mutations of the recombinase-activating genes 1 and 2 (RAG1 and RAG2) in humans are associated with a broad range of phenotypes. For patients with severe clinical presentation, hematopoietic stem cell transplantation (HSCT) represents the only curative treatment; however, high rates of graft failure...

Full description

Bibliographic Details
Authors: Dobbs, Kerry; Tabellini, Giovanna; Calzoni, Enrica; Patrizi, Ornella; Martinez, Paula; Giliani, Silvia Clara; Moratto, Daniele; Al-Herz, Waleed; Cancrini, Caterina; Cowan, Morton; Bleesing, Jacob; Booth, Claire; Buchbinder, David; Burns, Siobhan O.; Chatila, Talal A.; Chou, Janet; Daza-Cajigal, Vanessa; de Bruin, Lisa M. Ott; de la Morena, Maite; Di Matteo, Gigliola; Finocchi, Andrea; Geha, Raif; Goyal, Rakesh K.; Hayward, Anthony; Holland, Steven; Huang, Chiung-Hui; Kanariou, Maria G.; King, Alejandra; Kaplan, Blanka; Kleva, Anastasiya; Kuijpers, Taco W.; Lee, Bee Wah; Lougaris, Vassilios; Massaad, Michel; Meyts, Isabelle; Morsheimer, Megan; Neven, Benedicte; Pai, Sung-Yun; Plebani, Alessandro; Prockop, Susan; Reisli, Ismail; Soh, Jian Yi; Somech, Raz; Torgerson, Troy R.; Kim, Yae-Jaen; Walter, Jolan E.; Gennery, Andrew R.; Keles, Sevgi; Manis, John P.; Marcenaro, Emanuela; Moretta, Alessandro; Parolini, Silvia; Notarangelo, Luigi D.
Format: Article
Publication date:2017
Country:España
Institution:Conselleria de Salut i Consum del Govern de les Illes Balears
Repository:Docusalut
Language:English
OAI Identifier:oai:docusalut.com:20.500.13003/9743
Online Access:https://hdl.handle.net/20.500.13003/9743
Access Level:Open access
Keyword:natural killer cells
recombinase-activating genes
non-homologous end joining
immunodeficiency
CD56
interferon-gamma
degranulation
_version_ 1878739967597871104
author Dobbs, Kerry
author2 Tabellini, Giovanna
Calzoni, Enrica
Patrizi, Ornella
Martinez, Paula
Giliani, Silvia Clara
Moratto, Daniele
Al-Herz, Waleed
Cancrini, Caterina
Cowan, Morton
Bleesing, Jacob
Booth, Claire
Buchbinder, David
Burns, Siobhan O.
Chatila, Talal A.
Chou, Janet
Daza-Cajigal, Vanessa
de Bruin, Lisa M. Ott
de la Morena, Maite
Di Matteo, Gigliola
Finocchi, Andrea
Geha, Raif
Goyal, Rakesh K.
Hayward, Anthony
Holland, Steven
Huang, Chiung-Hui
Kanariou, Maria G.
King, Alejandra
Kaplan, Blanka
Kleva, Anastasiya
Kuijpers, Taco W.
Lee, Bee Wah
Lougaris, Vassilios
Massaad, Michel
Meyts, Isabelle
Morsheimer, Megan
Neven, Benedicte
Pai, Sung-Yun
Plebani, Alessandro
Prockop, Susan
Reisli, Ismail
Soh, Jian Yi
Somech, Raz
Torgerson, Troy R.
Kim, Yae-Jaen
Walter, Jolan E.
Gennery, Andrew R.
Keles, Sevgi
Manis, John P.
Marcenaro, Emanuela
Moretta, Alessandro
Parolini, Silvia
Notarangelo, Luigi D.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_browse Al-Herz, Waleed
Bleesing, Jacob
Booth, Claire
Buchbinder, David
Burns, Siobhan O.
Calzoni, Enrica
Cancrini, Caterina
Chatila, Talal A.
Chou, Janet
Cowan, Morton
Daza-Cajigal, Vanessa
Di Matteo, Gigliola
Dobbs, Kerry
Finocchi, Andrea
Geha, Raif
Gennery, Andrew R.
Giliani, Silvia Clara
Goyal, Rakesh K.
Hayward, Anthony
Holland, Steven
Huang, Chiung-Hui
Kanariou, Maria G.
Kaplan, Blanka
Keles, Sevgi
Kim, Yae-Jaen
King, Alejandra
Kleva, Anastasiya
Kuijpers, Taco W.
Lee, Bee Wah
Lougaris, Vassilios
Manis, John P.
Marcenaro, Emanuela
Martinez, Paula
Massaad, Michel
Meyts, Isabelle
Moratto, Daniele
Moretta, Alessandro
Morsheimer, Megan
Neven, Benedicte
Notarangelo, Luigi D.
Pai, Sung-Yun
Parolini, Silvia
Patrizi, Ornella
Plebani, Alessandro
Prockop, Susan
Reisli, Ismail
Soh, Jian Yi
Somech, Raz
Tabellini, Giovanna
Torgerson, Troy R.
Walter, Jolan E.
de Bruin, Lisa M. Ott
de la Morena, Maite
author_facet Dobbs, Kerry
Tabellini, Giovanna
Calzoni, Enrica
Patrizi, Ornella
Martinez, Paula
Giliani, Silvia Clara
Moratto, Daniele
Al-Herz, Waleed
Cancrini, Caterina
Cowan, Morton
Bleesing, Jacob
Booth, Claire
Buchbinder, David
Burns, Siobhan O.
Chatila, Talal A.
Chou, Janet
Daza-Cajigal, Vanessa
de Bruin, Lisa M. Ott
de la Morena, Maite
Di Matteo, Gigliola
Finocchi, Andrea
Geha, Raif
Goyal, Rakesh K.
Hayward, Anthony
Holland, Steven
Huang, Chiung-Hui
Kanariou, Maria G.
King, Alejandra
Kaplan, Blanka
Kleva, Anastasiya
Kuijpers, Taco W.
Lee, Bee Wah
Lougaris, Vassilios
Massaad, Michel
Meyts, Isabelle
Morsheimer, Megan
Neven, Benedicte
Pai, Sung-Yun
Plebani, Alessandro
Prockop, Susan
Reisli, Ismail
Soh, Jian Yi
Somech, Raz
Torgerson, Troy R.
Kim, Yae-Jaen
Walter, Jolan E.
Gennery, Andrew R.
Keles, Sevgi
Manis, John P.
Marcenaro, Emanuela
Moretta, Alessandro
Parolini, Silvia
Notarangelo, Luigi D.
author_role author
collection Docusalut
description Mutations of the recombinase-activating genes 1 and 2 (RAG1 and RAG2) in humans are associated with a broad range of phenotypes. For patients with severe clinical presentation, hematopoietic stem cell transplantation (HSCT) represents the only curative treatment; however, high rates of graft failure and incomplete immune reconstitution have been observed, especially after unconditioned haploidentical transplantation. Studies in mice have shown that Rag-/-natural killer (NK) cells have a mature phenotype, reduced fitness, and increased cytotoxicity. We aimed to analyze NK cell phenotype and function in patients with mutations in RAG and in non-homologous end joining (NHEJ) genes. Here, we provide evidence that NK cells from these patients have an immature phenotype, with significant expansion of CD56(bright) CD16(-/int) CD57(-cells), yet increased degranulation and high perforin content. Correlation was observed between in vitro recombinase activity of the mutant proteins, NK cell abnormalities, and in vivo clinical phenotype. Addition of serotherapy in the conditioning regimen, with the aim of depleting the autologous NK cell compartment, may be important to facilitate engraftment and immune reconstitution in patients with RAG and NHEJ defects treated by HSCT.
eu_rights_str_mv openAccess
format article
id ES_cb4e1f7eb34c9c60dc5f3ee733fa8b7f
institution Conselleria de Salut i Consum del Govern de les Illes Balears
instname_str Conselleria de Salut i Consum del Govern de les Illes Balears
language eng
network_acronym_str ES
network_name_str España
oai_identifier_str oai:docusalut.com:20.500.13003/9743
publishDate 2017
publishDateSort 2017
publisher Frontiers Media Sa
publisherStr Frontiers Media Sa
reponame_str Docusalut
spelling Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content Dobbs, Kerry Tabellini, Giovanna Calzoni, Enrica Patrizi, Ornella Martinez, Paula Giliani, Silvia Clara Moratto, Daniele Al-Herz, Waleed Cancrini, Caterina Cowan, Morton Bleesing, Jacob Booth, Claire Buchbinder, David Burns, Siobhan O. Chatila, Talal A. Chou, Janet Daza-Cajigal, Vanessa de Bruin, Lisa M. Ott de la Morena, Maite Di Matteo, Gigliola Finocchi, Andrea Geha, Raif Goyal, Rakesh K. Hayward, Anthony Holland, Steven Huang, Chiung-Hui Kanariou, Maria G. King, Alejandra Kaplan, Blanka Kleva, Anastasiya Kuijpers, Taco W. Lee, Bee Wah Lougaris, Vassilios Massaad, Michel Meyts, Isabelle Morsheimer, Megan Neven, Benedicte Pai, Sung-Yun Plebani, Alessandro Prockop, Susan Reisli, Ismail Soh, Jian Yi Somech, Raz Torgerson, Troy R. Kim, Yae-Jaen Walter, Jolan E. Gennery, Andrew R. Keles, Sevgi Manis, John P. Marcenaro, Emanuela Moretta, Alessandro Parolini, Silvia Notarangelo, Luigi D. natural killer cells recombinase-activating genes non-homologous end joining immunodeficiency CD56 interferon-gamma degranulation Mutations of the recombinase-activating genes 1 and 2 (RAG1 and RAG2) in humans are associated with a broad range of phenotypes. For patients with severe clinical presentation, hematopoietic stem cell transplantation (HSCT) represents the only curative treatment; however, high rates of graft failure and incomplete immune reconstitution have been observed, especially after unconditioned haploidentical transplantation. Studies in mice have shown that Rag-/-natural killer (NK) cells have a mature phenotype, reduced fitness, and increased cytotoxicity. We aimed to analyze NK cell phenotype and function in patients with mutations in RAG and in non-homologous end joining (NHEJ) genes. Here, we provide evidence that NK cells from these patients have an immature phenotype, with significant expansion of CD56(bright) CD16(-/int) CD57(-cells), yet increased degranulation and high perforin content. Correlation was observed between in vitro recombinase activity of the mutant proteins, NK cell abnormalities, and in vivo clinical phenotype. Addition of serotherapy in the conditioning regimen, with the aim of depleting the autologous NK cell compartment, may be important to facilitate engraftment and immune reconstitution in patients with RAG and NHEJ defects treated by HSCT. Frontiers Media Sa https://hdl.handle.net/20.500.13003/9743
spellingShingle Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
Dobbs, Kerry
natural killer cells
recombinase-activating genes
non-homologous end joining
immunodeficiency
CD56
interferon-gamma
degranulation
title Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
title_full Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
title_fullStr Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
title_full_unstemmed Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
title_short Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
title_sort Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
topic natural killer cells
recombinase-activating genes
non-homologous end joining
immunodeficiency
CD56
interferon-gamma
degranulation
topic_facet natural killer cells
recombinase-activating genes
non-homologous end joining
immunodeficiency
CD56
interferon-gamma
degranulation
url https://hdl.handle.net/20.500.13003/9743